FDA approves 1st drug for moderate and severe eczema cases

... list price of $37,000 per year, according to Paris, France-based Sanofi SA and Regeneron Pharmaceuticals of Tarrytown, New York, which developed the drug. Eczema treatments have generally been limited to topical medications, steroid creams, ...
http://ift.tt/2o7kk71